BAP1 and nonpapillary renal cell carcinoma: By correlating imaging features with molecular markers such as VHL, PBRM1, and BAP1 mutations, AI facilitates non-invasive prediction of genetic profiles, paving the way for personalized treatment approaches in ccRCC.